Vertex Pharmaceuticals, Inc.

{
  "main_header": {
    "sid": 1162439,
    "name": "Vertex Pharmaceuticals, Inc.",
    "stock_name": "Vertex Pharmaceuticals, Inc.",
    "full_name": "Vertex Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/vertex-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "468.41",
    "chg": 1.06,
    "chgp": "0.23%",
    "dir": 1,
    "prev_price": "467.35",
    "mcapval": "116,999.90",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US92532F1003",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "875.93 k",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vertex-pharmaceuticals-inc-1162439-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Vertex Pharmaceuticals, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vertex-pharmaceuticals-valuation-grade-downgraded-from-attractive-to-fair-amid-stock-price-increase-3667136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/VertexPharmaceu_valuationdot_3667136.png",
        "date": "2025-11-03 16:00:53",
        "description": "Vertex Pharmaceuticals has adjusted its valuation amid changes in financial metrics and market positioning. The company reported a recent price of $425.57, with a negative stock return over the past year. Key indicators show it is currently loss-making, reflecting competitive dynamics within the pharmaceuticals and biotechnology sector."
      }
    ],
    "total": 12,
    "sid": "1162439",
    "stock_news_url": "https://www.marketsmojo.com/news/vertex-pharmaceuticals-inc-1162439"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Vertex Pharmaceuticals, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics

2025-11-03 16:00:53

Vertex Pharmaceuticals has adjusted its valuation amid changes in financial metrics and market positioning. The company reported a recent price of $425.57, with a negative stock return over the past year. Key indicators show it is currently loss-making, reflecting competitive dynamics within the pharmaceuticals and biotechnology sector.

Read full news article

View All News